Difference between revisions of "Unfractionated heparin"
Neil.m.young (talk | contribs) |
Neil.m.young (talk | contribs) |
||
Line 46: | Line 46: | ||
==Pharmacology== | ==Pharmacology== | ||
− | *Half-life: | + | *Half-life: 1.5 hrs |
− | *Metabolism: | + | *Metabolism: Hepatic |
− | *Excretion: | + | *Excretion: Urine |
*Mechanism of Action: | *Mechanism of Action: | ||
− | + | **Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin | |
− | |||
− | *Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin | ||
*Anticoagulation effect lasts up to 3hr after stopping infusion | *Anticoagulation effect lasts up to 3hr after stopping infusion | ||
*Must give IV (not subq) for acute thromboembolic disease | *Must give IV (not subq) for acute thromboembolic disease |
Revision as of 17:22, 6 March 2016
Contents
General
- Type: Anticoagulant
- Dosage Forms: IV, SC
- Common Trade Names: Heparin
Adult Dosing
Thromboembolism
- Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)
- Then drip: 18 units/kg/h IV (MAX: 1,000 units/h)
- Adjust dose to target aPTT levels based on nomogram
PCI
Pediatric Dosing
- IV infusion
- Initial loading dose 75 units/kg given over 10 minutes
- Initial maintenance dose 20 units/kg/hour and adjest per local policy
Special Populations
- Pregnancy Rating: Safe in pregnancy
- Lactation:
- Renal Dosing
- No adjustment
- Hepatic Dosing
- No adjustment
Contraindications
- Allergy to class/drug
- 33% of pts develop some form of bleeding complication; 2-6% develop major bleeding
- Heparin-Induced Thrombocytopenia
- See HIT (Heparin-Induced Thrombocytopenia)
Risk Factors for Major Bleeding Complication
- Recent surgery or trauma
- Renal failure
- Alcoholism
- Malignancy
- Liver failure
- Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs
Pharmacology
- Half-life: 1.5 hrs
- Metabolism: Hepatic
- Excretion: Urine
- Mechanism of Action:
- Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin
- Anticoagulation effect lasts up to 3hr after stopping infusion
- Must give IV (not subq) for acute thromboembolic disease
- Unpredictable anticoagulation effect
- Must monitor w/ PTT; therapeutic range is 1.5-2.5x normal value